Abstract
The treatment of people with epilepsy exposes clinicians to potential liability should seizures result in catastrophic consequences, in the absence of adequate advice being proffered. The period during a change of an anti-seizure medication (ASM) regimen heightens this risk with inherent anxiety for both prescribers and patients.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
